News

Published on 2 Nov 2023 on GuruFocus.com via Yahoo Finance

DermTech Inc (DMTK) Reports 10% Increase in Total Revenue for Q3 2023


Article preview image

Test revenue for DermTech Inc (NASDAQ:DMTK) increased by 8% in Q3 2023 compared to the same period in 2022.The Average Selling Price (ASP) for the DermTech Melanoma Test (DMT) saw a 24% year-over-year increase.Operating expenses significantly declined in Q3 2023, with a 35% decrease in net cash burn from the full-year 2022.The company's cash runway is projected to extend into the first quarter of 2025.

Warning! GuruFocus has detected 7 Warning Signs with DMTK.

On November 2, 2023, DermTech Inc (NASDAQ:DMTK), a leader in precision dermatology, released its third-quarter 2023 financial results. The company reported a significant improvement in key performance indicators, including a growth in ASP and test revenue on a year-over-year and sequential basis. The Medicare proportion of billable samples also expanded from 23% to a record high of 27% in the last two quarters.

NASDAQ.DMTK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Shareholders in DermTech, Inc. (NASDAQ:DMTK) had a terrible week, as shares crashed 31% to US$0.8...

Simply Wall St. via Yahoo Finance 3 Mar 2024

DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript

DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript February 29, 2024 DermTech, Inc. mi...

Insider Monkey via Yahoo Finance 2 Mar 2024

DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates

DermTech, Inc. (DMTK) came out with a quarterly loss of $0.56 per share versus the Zacks Consensu...

Zacks via Yahoo Finance 29 Feb 2024

Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket -...

Gainers Altamira Therapeutics Ltd CYTO shares surged 54.1% to $0.25 in pre-market trading after g...

Benzinga 3 Nov 2023

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday’s...

Now Read This: Top 4 Financial Stocks That May Collapse This Quarter

Benzinga 3 Nov 2023

DermTech Inc (DMTK) Reports 10% Increase in Total Revenue for Q3 2023

Test revenue for DermTech Inc (NASDAQ:DMTK) increased by 8% in Q3 2023 compared to the same perio...

GuruFocus.com via Yahoo Finance 2 Nov 2023

Insider Sell: DermTech Inc CFO Kevin Sun Sells 9,616 Shares

On September 11, 2023, Kevin Sun, the Chief Financial Officer (CFO) of DermTech Inc (NASDAQ:DMTK)...

GuruFocus.com via Yahoo Finance 13 Sep 2023

Is DiaMedica Therapeutics (DMAC) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 31 Aug 2023

DermTech, Inc. (DMTK) Reports Q2 Loss, Tops Revenue Estimates

DermTech, Inc. (DMTK) came out with a quarterly loss of $0.99 per share versus the Zacks Consensu...

Zacks via Yahoo Finance 3 Aug 2023

DermTech, Inc. (NASDAQ:DMTK) surges 21%; retail investors who own 59% shares profited along with...

Key Insights The considerable ownership by retail investors in DermTech indicates that they colle...

Simply Wall St. via Yahoo Finance 13 Jul 2023